Product
Supplier
Encyclopedia
Inquiry
220127-57-1 | ChemExpress buy - large image1
220127-57-1 | ChemExpress buy - image1

220127-57-1 | ChemExpress

1 Inquiries

Unit Price: Get Latest Price
CAS No.:

220127-57-1

Port:

shanghai

Packaging:

10 kg

Price valid (until):

2024-04-01

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

CRO

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Imatinib mesylate

    API of Imatinib mesylate
    We can provide high-quality Imatinib mesylate and its derived impurities.


    Brand:ChemExpress
    CAS:220127-57-1
    Catalog_No:HY-50946
    Molecular Formular:C30H35N7O4S
    Molecular Weight:589.71


    Contact:
    TEL:+1-970-439-2030 (USA)、+86 (21) 5895-0125 (Global)
    Email:info@chemexpress.com



    Brand Introduction:
    ChemExpress focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. Our comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. We are a one-stop service platform to support our client’s projects from early drug discovery, process development to commercialization.


    ChemExpress Services:
     
    Drug Discovery: synthetic chemistry; medicine chemistry; FTE/FFS services.

    Process Development: APIs and intermediates development; formulation development.

    New Modalities Development: ADC; peptide; oligonucleotide and so on.

    Manufactory: support production from milligrams to kilograms, both with GMP and non-GMP capabilities.

    Analytical Development & Quality Control: R&D testing; stability study; genotoxic impurity research and so on.

    Regulatory CMC Support

    Eany development services in Synthetic Chemistny:Providing serices related to high qualty compound synthesis,chemical custom synthesis and analytical chemistry.

    Pharmaceutical Chemistry eaniy development services: including high-throughput screening, drug synthesis, seding compounds, lead compounds, and IND fling support.

    Process development: Covers AP! & intermediates process development, validation, transfer, and formulation development.

    Commerial producion:it hasa research and development base forthe producion otapis intermediates and prenarations and provdes commeria prouction semices.

    CMC services: Provide one-stop CMC services, from lND to NDA stage of pharmaceutical research and development and dedlaration services, accelerate IND declaration.

    ADC drug and highly active drug development and production:  Provides a one-stop CRO & CDMO service for the small molecule aspect of ADC drugs, as well as customized ADC conjugation services. 

    Oligonucleotide drug process development and production: Provide oligonucleotide customized products and services to meet different needs.

    Analytical testing services and quality control: Provide integrated analytical testing services and drug quality research support

    ChemExpress committed to being a steadfast companion for our clients, gaining profound insight into their needs. Our focus is on accelerating the empowerment of global partners across the full spectrum, from preclinical stages to commercial production. This commitment aims for more streamlined drug development, swifter market entry, and an earlier positive impact on human health.


    Product details:https://www.chemexpress.com/product/HY-50946

    ECHEMI Editorial Reference
    Imatinib Mesylate is a tyrosine kinases inhibitor that inhibits c-Kit, Bcr-Abl, and PDGFR (IC50=100 nM) tyrosine kinases.
    Imatinib methanesulfonate is a methanesulfonate (mesylate) salt that is the monomesylate salt of imatinib. Used for treatment of chronic myelogenous leukemia and gastrointestinal stromal tumours. It has a role as an antineoplastic agent, an apoptosis inducer, a tyrosine kinase inhibitor and an anticoronaviral agent. It contains an imatinib.|Imatinib Mesylate is the mesylate salt of imatinib, a tyrosine kinase inhibitor with antineoplastic activity. Imatinib binds to an intracellular pocket located within tyrosine kinases (TK), thereby inhibiting ATP binding and preventing phosphorylation and the subsequent activation of growth receptors and their downstream signal transduction pathways. This agent inhibits TK encoded by the bcr-abl oncogene as well as receptor TKs encoded by the c-kit and platelet-derived growth factor receptor (PDGFR) oncogenes. Inhibition of the bcr-abl TK results in decreased proliferation and enhanced apoptosis in malignant cells of Philadelphia-positive (Ph+) hematological malignancies such as CML and ALL; effects on c-kit TK activity inhibit mast-cell and cellular proliferation in those diseases overexpressing c-kit, such as mastocytosis and gastrointestinal stromal tumor (GIST).|A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors.

    Basic Info
    Product Name:

    Imatinib mesylate

    Other Name:

    Benzamide,4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-,methanesulfonate (1:1);Benzamide,4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-,monomethanesulfonate;Imatinib mesilate;Imatinib mesylate;CGP 57148B;STI 571;Glivec;Gleevac;Gleevec;1-Methyl-4-(4-((4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)carbamoyl)benzyl)piperazine methanesulfonate;Mitinab;ST 571

    CAS No.:

    220127-57-1

    Molecular Formula:

    C29H31N7O.CH4O3S

    InChIKeys:

    InChIKey=YLMAHDNUQAMNNX-UHFFFAOYSA-N

    Molecular Weight:

    589.70800

    Exact Mass:

    589.24700

    EC Number:

    606-892-3

    UNII:

    8A1O1M485B

    NSC Number:

    716051

    DSSTox ID:

    DTXSID9040502

    NCI Thesaurus Code:

    C1687

    Color/Form:

    White to off white to brownish or yellowish tinged crystalline powder

    ATC Code:

    L01XE01

    HScode:

    2933990090

    Characteristics
    PSA:

    149.03000

    XLogP3:

    5.19690

    Appearance:

    white crystalline powder .

    Density:

    0.858 g/mL at 25 °C(lit.)

    Melting Point:

    146-148 °C

    Boiling Point:

    754.9ºC at 760 mmHg

    Flash Point:

    410.3ºC

    Refractive Index:

    n20/D 1.401(lit.)

    Water Solubility:

    In water, >100 g/l @ pH 4.2; 49 mg/l @ pH 7.4

    Experimental Properties:

    Lipophilic at pH 7.4|Molecular weight: 493.60; melting point: 211-213 °C; pKa1: 8.07; pKa2: 3.73; pKa3: 2.56; pKa 4: 1.52 /Imatinib/

    Hazard Identification

    Classification of the substance or mixture

    Acute toxicity - Category 4, Oral

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H302 Harmful if swallowed

    Precautionary statement(s)
    Prevention

    P264 Wash ... thoroughly after handling.

    P270 Do not eat, drink or smoke when using this product.

    Response

    P301+P317 IF SWALLOWED: Get medical help.

    P330 Rinse mouth.

    Storage

    none

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    CRO

    Location:

    1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA

    Payment Terms:

    TT against copy of documents

    Average lead Time:

    3

    Total Annual Revenue:

    $2.5 million-$5 million

    Total Employees:

    Above 1000

    Year of Establishment:

    2006

    Company Profile

    Founded in 2006, ChemExpress focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. Our comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. We are a one-stop service platform to support our client’s projects from early drug discovery, process development to commercialization.

    Over the past 17 years, we have established a state-of-the-art QC/QA system aligning with ICH guidelines for pharmaceutical manufacturing. We provide our clients with high-quality products and CMC services across the entire life-cycle of drug development.


  • Inquiry History
    1 Inquiries
    Country Product Purchase Quantity Date Posted
    Bangladesh

    Imatinib Mesylate

    2100 G Oct 27, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.